PIWIL2-DT: A Drug Target / Disease Biomarker (G100507071)

Target Name: PIWIL2-DT

NCBI ID: G100507071

PIWIL2-DT

Other Name(s): PIWIL2 divergent transcript

PIWIL2-DT: A Drug Target / Disease Biomarker

Piwil2-DT is a protein that is expressed in the brain and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The protein is a key component of the huntingtin (HTT) family, which is a family of transmembrane proteins that are involved in a variety of cellular processes, including axon growth, cell survival, and neurotransmitter release.

Research has shown that Piwil2-DT is involved in the regulation of a variety of cellular processes, including the transport of neurotransmitters, the maintenance of the blood-brain barrier, and the regulation of inflammation. It is also involved in the development and progression of neurodegenerative diseases, which is why it is a promising drug target for the development of new treatments for these diseases.

One of the key functions of Piwil2-DT is its role in the regulation of neurotransmitter release. This is important for the function of the brain, as neurotransmitters are the molecules that carry signals from the brain to other parts of the body. The regulation of neurotransmitter release is critical for the proper functioning of the brain, and Piwil2-DT is involved in this process.

In addition to its role in neurotransmitter release, Piwil2-DT is also involved in the regulation of the blood-brain barrier. The blood-brain barrier is a barrier that separates the brain from the rest of the body, and it is designed to protect the brain from harmful substances that could be harmful to it. Piwil2-DT is involved in the regulation of the blood-brain barrier, which allows it to do its job in protecting the brain.

Another function of Piwil2-DT is its role in the regulation of inflammation. Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are often associated with inflammation in the brain. Piwil2-DT is involved in the regulation of inflammation in the brain, which may help to protect the brain from the harmful effects of inflammation.

In conclusion, Piwil2-DT is a protein that is expressed in the brain and is involved in a variety of cellular processes that are important for the proper functioning of the brain. It is a promising drug target for the development of new treatments for neurodegenerative diseases. Further research is needed to fully understand the role of Piwil2-DT in these diseases and to develop new treatments.

Protein Name: PIWIL2 Divergent Transcript

The "PIWIL2-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIWIL2-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets